Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Non-oncology Biopharmaceuticals Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Non-oncology Biopharmaceuticals Market Status and Forecast (2016-2027)
      • 1.3.2 Global Non-oncology Biopharmaceuticals Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Non-oncology Biopharmaceuticals Supply by Company

    • 2.1 Global Non-oncology Biopharmaceuticals Sales Volume by Company
    • 2.2 Global Non-oncology Biopharmaceuticals Sales Value by Company
    • 2.3 Global Non-oncology Biopharmaceuticals Price by Company
    • 2.4 Non-oncology Biopharmaceuticals Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Non-oncology Biopharmaceuticals Market Status by Category

    • 3.1 Non-oncology Biopharmaceuticals Category Introduction
      • 3.1.1 Biologics
      • 3.1.2 Biosimilars
    • 3.2 Global Non-oncology Biopharmaceuticals Market by Category
      • 3.2.1 Global Non-oncology Biopharmaceuticals Sales Volume by Category (2016-2021)
      • 3.2.2 Global Non-oncology Biopharmaceuticals Sales Value by Category (2016-2021)
      • 3.2.3 Global Non-oncology Biopharmaceuticals Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Non-oncology Biopharmaceuticals Market Status by End User/Segment

    • 4.1 Non-oncology Biopharmaceuticals Segment by End User/Segment
      • 4.1.1 Immunology
      • 4.1.2 Endocrinology
      • 4.1.3 Others
    • 4.2 Global Non-oncology Biopharmaceuticals Market by End User/Segment
      • 4.2.1 Global Non-oncology Biopharmaceuticals Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Non-oncology Biopharmaceuticals Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Non-oncology Biopharmaceuticals Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Non-oncology Biopharmaceuticals Market Status by Region

    • 5.1 Global Non-oncology Biopharmaceuticals Market by Region
      • 5.1.1 Global Non-oncology Biopharmaceuticals Sales Volume by Region
      • 5.1.2 Global Non-oncology Biopharmaceuticals Sales Value by Region
    • 5.2 North America Non-oncology Biopharmaceuticals Market Status
    • 5.3 Europe Non-oncology Biopharmaceuticals Market Status
    • 5.4 Asia Pacific Non-oncology Biopharmaceuticals Market Status
    • 5.5 Central & South America Non-oncology Biopharmaceuticals Market Status
    • 5.6 Middle East & Africa Non-oncology Biopharmaceuticals Market Status

    6 North America Non-oncology Biopharmaceuticals Market Status

    • 6.1 North America Non-oncology Biopharmaceuticals Market by Country
      • 6.1.1 North America Non-oncology Biopharmaceuticals Sales Volume by Country (2016-2021)
      • 6.1.2 North America Non-oncology Biopharmaceuticals Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Non-oncology Biopharmaceuticals Market Status

    • 7.1 Europe Non-oncology Biopharmaceuticals Market by Country
      • 7.1.1 Europe Non-oncology Biopharmaceuticals Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Non-oncology Biopharmaceuticals Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Non-oncology Biopharmaceuticals Market Status

    • 8.1 Asia Pacific Non-oncology Biopharmaceuticals Market by Country
      • 8.1.1 Asia Pacific Non-oncology Biopharmaceuticals Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Non-oncology Biopharmaceuticals Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Non-oncology Biopharmaceuticals Market Status

    • 9.1 Central & South America Non-oncology Biopharmaceuticals Market by Country
      • 9.1.1 Central & South America Non-oncology Biopharmaceuticals Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Non-oncology Biopharmaceuticals Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Non-oncology Biopharmaceuticals Market Status

    • 10.1 Middle East & Africa Non-oncology Biopharmaceuticals Market by Country
      • 10.1.1 Middle East & Africa Non-oncology Biopharmaceuticals Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Non-oncology Biopharmaceuticals Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Non-oncology Biopharmaceuticals Manufacturing Cost Analysis
    • 11.5 Non-oncology Biopharmaceuticals Sales Channel and Distributors Analysis
      • 11.5.1 Non-oncology Biopharmaceuticals Sales Channel
      • 11.5.2 Non-oncology Biopharmaceuticals Distributors
    • 11.6 Non-oncology Biopharmaceuticals Downstream Major Buyers

    12 Global Non-oncology Biopharmaceuticals Market Forecast by Category and by End User/Segment

    • 12.1 Global Non-oncology Biopharmaceuticals Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Non-oncology Biopharmaceuticals Forecast by Category
      • 12.2.1 Global Non-oncology Biopharmaceuticals Sales Volume Forecast by Category
      • 12.2.2 Global Non-oncology Biopharmaceuticals Sales Value Forecast by Category
      • 12.2.3 Global Non-oncology Biopharmaceuticals Price Forecast by Category
    • 12.3 Global Non-oncology Biopharmaceuticals Forecast by End User/Segment
      • 12.3.1 Global Non-oncology Biopharmaceuticals Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Non-oncology Biopharmaceuticals Sales Value Forecast by End User/Segment
      • 12.3.3 Global Non-oncology Biopharmaceuticals Price Forecast by End User/Segment

    13 Global Non-oncology Biopharmaceuticals Market Forecast by Region/Country

    • 13.1 Global Non-oncology Biopharmaceuticals Market Forecast by Region (2022-2027)
      • 13.1.1 Global Non-oncology Biopharmaceuticals Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Non-oncology Biopharmaceuticals Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 UCB Pharma
      • 14.1.1 Company Information
      • 14.1.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.1.3 UCB Pharma Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teva
      • 14.2.1 Company Information
      • 14.2.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.2.3 Teva Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Takeda
      • 14.3.1 Company Information
      • 14.3.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.3.3 Takeda Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Swedish Orphan Biovitrum
      • 14.4.1 Company Information
      • 14.4.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.4.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Sanofi
      • 14.5.1 Company Information
      • 14.5.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.5.3 Sanofi Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Roche
      • 14.6.1 Company Information
      • 14.6.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.6.3 Roche Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Pfizer
      • 14.7.1 Company Information
      • 14.7.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.7.3 Pfizer Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Novo Nordisk
      • 14.8.1 Company Information
      • 14.8.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.8.3 Novo Nordisk Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Novartis
      • 14.9.1 Company Information
      • 14.9.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.9.3 Novartis Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Mylan
      • 14.10.1 Company Information
      • 14.10.2 Non-oncology Biopharmaceuticals Product Introduction
      • 14.10.3 Mylan Non-oncology Biopharmaceuticals Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Merck
    • 14.12 LEO Pharma
    • 14.13 Johnson & Johnson
    • 14.14 GlaxoSmithKline
    • 14.15 Elusys Therapeutics
    • 14.16 Eli Lilly
    • 14.17 Bristol-Myers Squibb
    • 14.18 Boehringer Ingelheim
    • 14.19 Biogen
    • 14.20 AstraZeneca
    • 14.21 Amgen
    • 14.22 Alexion Pharmaceuticals
    • 14.23 AbbVie

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Non-oncology Biopharmaceuticals market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Non-oncology Biopharmaceuticals market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Biologics
      Biosimilars

      Segmented by End User/Segment
      Immunology
      Endocrinology
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      UCB Pharma
      Teva
      Takeda
      Swedish Orphan Biovitrum
      Sanofi
      Roche
      Pfizer
      Novo Nordisk
      Novartis
      Mylan
      Merck
      LEO Pharma
      Johnson & Johnson
      GlaxoSmithKline
      Elusys Therapeutics
      Eli Lilly
      Bristol-Myers Squibb
      Boehringer Ingelheim
      Biogen
      AstraZeneca
      Amgen
      Alexion Pharmaceuticals
      AbbVie
      Buy now